biologic

Thymoglobulin

Anti-thymocyte Globulin (Rabbit)

Loss of exclusivityMay 2011projected — 12-year biologic exclusivity estimate
CompanyGenzyme Corporation

Drug detail

Brand nameThymoglobulin
Active ingredientAnti-thymocyte Globulin (Rabbit)
Strength25MG
Dosage formFor Injection
RouteIntravenous
ModalityBiologic
FDA approvalMay 1999
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Thymoglobulin patent cliff — loss of exclusivity May 2011 | CliffBio